Literature DB >> 12509852

Correlation between extracellular glucose and seizure susceptibility in adult rats.

Evan M Schwechter1, Jana Velísková, Libor Velísek.   

Abstract

In adult diabetic patients, periods of hyperglycemia may be associated with exacerbation of focal seizures. Our objective was to determine in the adult rats the correlation between seizure susceptibility and extracellular glucose concentration in two models of seizures. Male rats were injected with two doses of streptozocin (40 mg/kg IP) on 2 consecutive days to induce diabetic hyperglycemia. Controls either received vehicle or were not injected. After 2 weeks, blood glucose concentration was measured, and the rats were subjected to flurothyl seizure test. Another group of rats received glucose solution (20%, 5 ml IP) 30 minutes before testing to induce nondiabetic hyperglycemia. Thresholds for flurothyl-induced clonic and tonic-clonic seizures were determined. Finally, in vitro epileptiform activity was induced in the entorhinal cortex-hippocampal slices from naive rats by perfusing with magnesium-free medium with various glucose concentrations. In additional slices, paired-pulse paradigm was determined in the perforant path. Susceptibility to clonic and tonic-clonic flurothyl-induced seizures positively correlated with blood glucose concentrations as the increased glucose concentration was associated with proconvulsant effects. Similarly, in the in vitro experiments, epileptiform activity was promoted by increased and suppressed by decreased glucose concentrations. Data indicate that, in the adult rats, high glucose concentrations are associated with proconvulsant effects.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12509852     DOI: 10.1002/ana.10415

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  29 in total

Review 1.  Diabetes and epilepsy in children and adolescents.

Authors:  M Loredana Marcovecchio; Marianna Immacolata Petrosino; Francesco Chiarelli
Journal:  Curr Diab Rep       Date:  2015-04       Impact factor: 4.810

2.  Ketones keep neurons alive.

Authors:  Carl E Stafstrom
Journal:  Epilepsy Curr       Date:  2006 May-Jun       Impact factor: 7.500

3.  Effects of glucose and glutamine concentration in the formulation of the artificial cerebrospinal fluid (ACSF).

Authors:  Je Hi An; Yuzhuo Su; Thomas Radman; Marom Bikson
Journal:  Brain Res       Date:  2008-04-15       Impact factor: 3.252

4.  Seizure tests distinguish intermittent fasting from the ketogenic diet.

Authors:  Adam L Hartman; Xiangrong Zheng; Emily Bergbower; Michiko Kennedy; J Marie Hardwick
Journal:  Epilepsia       Date:  2010-04-30       Impact factor: 5.864

Review 5.  Metabolism and epilepsy: Ketogenic diets as a homeostatic link.

Authors:  Susan A Masino; Jong M Rho
Journal:  Brain Res       Date:  2018-06-06       Impact factor: 3.252

Review 6.  Mitochondrial involvement and oxidative stress in temporal lobe epilepsy.

Authors:  Shane Rowley; Manisha Patel
Journal:  Free Radic Biol Med       Date:  2013-02-11       Impact factor: 7.376

7.  Regional neural activity within the substantia nigra during peri-ictal flurothyl generalized seizure stages.

Authors:  Jana Velísková; Alexandra M Miller; Magda L Nunes; Lucy L Brown
Journal:  Neurobiol Dis       Date:  2005-06-13       Impact factor: 5.996

8.  Rapamycin has age-, treatment paradigm-, and model-specific anticonvulsant effects and modulates neuropeptide Y expression in rats.

Authors:  Tamar Chachua; Ka-Lai Poon; Mi-Sun Yum; Leigh Nesheiwat; Kara DeSantis; Jana Velíšková; Libor Velíšek
Journal:  Epilepsia       Date:  2012-09-27       Impact factor: 5.864

9.  Diabetic hyperglycemia aggravates seizures and status epilepticus-induced hippocampal damage.

Authors:  Chin-Wei Huang; Juei-Tang Cheng; Jing-Jane Tsai; Sheng-Nan Wu; Chao-Ching Huang
Journal:  Neurotox Res       Date:  2009-02-18       Impact factor: 3.911

Review 10.  Mitochondria, oxidative stress, and temporal lobe epilepsy.

Authors:  Simon Waldbaum; Manisha Patel
Journal:  Epilepsy Res       Date:  2009-10-21       Impact factor: 3.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.